{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T10:00:00Z","timestamp":1776506400293,"version":"3.51.2"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1998,10,1]],"date-time":"1998-10-01T00:00:00Z","timestamp":907200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1998,10,1]],"date-time":"1998-10-01T00:00:00Z","timestamp":907200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[1998,10]]},"DOI":"10.1023\/a:1006175831785","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T00:53:09Z","timestamp":1040518389000},"page":"39-46","source":"Crossref","is-referenced-by-count":45,"title":["Acute leukemia following treatment of malignant glioma"],"prefix":"10.1007","volume":"40","author":[{"given":"James R.","family":"Perry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon P.","family":"Gockerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"185582_CR1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0360-3016(94)90222-4","volume":"29","author":"G Biti","year":"1994","unstructured":"Biti G, Cellai E, Magrini SM, Papi MG, Ponticelli P, Boddi V: Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution. Int J Rad Oncol Biol Phys 29: 25-31, 1994","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"185582_CR2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0889-8588(18)30246-6","volume":"7","author":"M Henry-Amar","year":"1993","unstructured":"Henry-Amar M, Dietrich P-Y: Acute leukemia after the treatment of Hodgkin's disease. Hematol Oncol Clin N Amer 7: 369-387, 1993","journal-title":"Hematol Oncol Clin N Amer"},{"key":"185582_CR3","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1200\/JCO.1984.2.7.762","volume":"2","author":"WJ Tester","year":"1984","unstructured":"Tester WJ, Kinsella TJ, Waller B, Makuch RW, Kelley PA, Glatstein E, De Vita VT: Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. J Clin Oncol 2: 762-769, 1984","journal-title":"J Clin Oncol"},{"key":"185582_CR4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00001622-199309000-00006","volume":"8","author":"P Valagussa","year":"1993","unstructured":"Valagussa P: Second neoplasms following treatment of Hodgkin's disease. Curr Opin Oncol 8: 805-811, 1993","journal-title":"Curr Opin Oncol"},{"key":"185582_CR5","first-page":"47","volume":"19","author":"EG Levine","year":"1992","unstructured":"Levine EG, Bloomfield CD: Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Sem Oncol 19: 47-84, 1992","journal-title":"Sem Oncol"},{"key":"185582_CR6","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJM198311033091802","volume":"309","author":"JD Boice Jr","year":"1983","unstructured":"Boice JD Jr, Greene MH, Killen JY Jr: Ellenberg SS, Kechn RJ, McFadden E, Chen TT, Fraumeni JF Jr: Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU). N Engl J Med 309: 1079-1084, 1983","journal-title":"N Engl J Med"},{"key":"185582_CR7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/jnci\/87.1.58","volume":"87","author":"C Bokemeyer","year":"1995","unstructured":"Bokemeyer C, Schmoll H-J, Kuczyk MA, Beyer J, Siegart W: Risk of secondary leukemia following high cumulative doses of Etoposide during chemotherapy for testicular cancer. J Natl Cancer Inst 87: 58-60, 1995","journal-title":"J Natl Cancer Inst"},{"key":"185582_CR8","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJM199206253262605","volume":"326","author":"RE Curtis","year":"1992","unstructured":"Curtis RE, Boice JD Jr, Stovall M, Bernstein L, Greenberg RS, Flannery JT, Schwartz AG, Weyer P, Moloney WC, Hoover RN: Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 326: 1745-1751, 1992","journal-title":"N Engl J Med"},{"key":"185582_CR9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0165-4608(95)00045-Q","volume":"82","author":"H Demuynck","year":"1995","unstructured":"Demuynck H, Verhoef GEG, Zachee P, Vandenberghe P, Van Orshoven A, Paridaens R, Samson I, Boogaerdts: Therapy-related acute myeloid leukemia with t(8;16)(p11;p13) following anthracycline-based therapy for nonmetastatic osteosarcoma. Cancer Genet Cytogenet 82: 103-105, 1995","journal-title":"Cancer Genet Cytogenet"},{"key":"185582_CR10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/02841869409121768","volume":"33","author":"P Hahn","year":"1994","unstructured":"Hahn P, Nelson N, Baral E: Leukemia in patients with breast cancer following adjuvant chemotherapy and\/or postoperative radiation therapy. Acta Oncol 33: 599-602, 1994","journal-title":"Acta Oncol"},{"key":"185582_CR11","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1182\/blood.V66.6.1393.1393","volume":"66","author":"J Pederson-Bjergaard","year":"1985","unstructured":"Pederson-Bjergaard J, Osterlind K, Hansen M, Philip P, Pedersen AG, Hansen HH: Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lung. Blood 66: 1393-1397, 1985","journal-title":"Blood"},{"key":"185582_CR12","first-page":"1257","volume":"60","author":"RJ Cohen","year":"1976","unstructured":"Cohen RJ, Wiernik PH, Walker MD: Acute nonlymphocytic leukemia associated with nitrosourea chemotherapy: report of two cases. Cancer Treat Rep 60: 1257-1261, 1976","journal-title":"Cancer Treat Rep"},{"key":"185582_CR13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1227\/00006123-198209000-00012","volume":"11","author":"GR Robustelli della Cuna","year":"1982","unstructured":"Robustelli della Cuna GR, Paoletti P, Bernardo G, Knerich R, Butti G, Cuzzoni Q: Clinical toxicity of combined modality treatment of nitrosourea derivatives for central nervous system tumors. Neurosurgery 11: 408-411, 1982","journal-title":"Neurosurgery"},{"key":"185582_CR14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/1097-0142(19830715)52:2<222::AID-CNCR2820520207>3.0.CO;2-K","volume":"52","author":"J-Y Genot","year":"1983","unstructured":"Genot J-Y, Krulik M, Poisson M, Van Efferterre R, Renoux M, Audebert AA, Canuel C, Smadja N, Debray J: Two cases of acute leukemia following treatment of malignant glioma. Cancer 52: 222-226, 1983","journal-title":"Cancer"},{"key":"185582_CR15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJM198507183130301","volume":"313","author":"MH Greene","year":"1985","unstructured":"Greene MH, Bice JD Jr, Strike TA: Carmustine as a cause of acute nonlymphocytic leukemia [letter]. N Engl J Med 313: 579, 1985","journal-title":"N Engl J Med"},{"key":"185582_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-4608(91)90187-Y","volume":"57","author":"K Heimdal","year":"1991","unstructured":"Heimdal K, Evensen SA, Fossa SD, Hirschberg H, Langholm R, Brogger A, Moller P: Karyotyping of a hematologic neoplasia developing shortly after treatment for cerebral extragonadal germ cell tumor. Cancer Genet Cytogenet 57: 41-46, 1991","journal-title":"Cancer Genet Cytogenet"},{"key":"185582_CR17","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1001\/archneur.1982.00510220062016","volume":"39","author":"J Hildebrand","year":"1982","unstructured":"Hildebrand J, Malarme M, Flament-Durand J, Struckmans P: Acute nonlymphoblastic leukemia in a patient treated for brain tumor. Arch Neurol 39: 664-665, 1982","journal-title":"Arch Neurol"},{"key":"185582_CR18","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3171\/jns.1984.60.6.1287","volume":"60","author":"S Kempin","year":"1984","unstructured":"Kempin S, Sundaresan N, Shapiro WB, Arlin Z, Acute nonlymphocytic leukemia following treatment of malignant glioma. Report of two cases. J Neurosurg 60: 1287-1290, 1984","journal-title":"J Neurosurg"},{"key":"185582_CR19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00000421-199502000-00018","volume":"18","author":"R Krywicki","year":"1995","unstructured":"Krywicki R, Bowen K, Anderson L, Garland D, Cobb P, Jenkins T, O'Rourke T: Mixed-lineage acute myeloid leukemia associated with a suprasellar dysgerminoma. Am J Clin Oncol 18: 83-86, 1995","journal-title":"Am J Clin Oncol"},{"key":"185582_CR20","first-page":"303","volume":"18","author":"M Osband","year":"1977","unstructured":"Osband M, Cohen H, Cassady R, Jaffe N: Severe and protracted bone marrow dysfunction following long-term therapy with methyl-CCNU [abstract]. Proc Am Soc Clin Oncol 18: 303, 1977","journal-title":"Proc Am Soc Clin Oncol"},{"key":"185582_CR21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/1097-0142(19870715)60:2<173::AID-CNCR2820600209>3.0.CO;2-F","volume":"60","author":"TZ Baram","year":"1987","unstructured":"Baram TZ, van Eys J, Dowell RE, Cangir A, Pack B, Bruner JM: Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy. Cancer 60: 173-177, 1987","journal-title":"Cancer"},{"key":"185582_CR22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/08880019109033430","volume":"8","author":"J Blatt","year":"1991","unstructured":"Blatt J, Penchansky L, Phebus C, Horn M: Leukemia in a child with a history of medulloblastoma. Ped Hematol Oncol 8: 77-82, 1991","journal-title":"Ped Hematol Oncol"},{"key":"185582_CR23","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/mpo.2950110212","volume":"11","author":"TE Goffman","year":"1983","unstructured":"Goffman TE, Woo SY, Manz H, McCullough D, Sinks LF, Chun BK, Miller RW: Ependymoma, glioblastoma, and acute leukemia in a child. Med Ped Oncol 11: 130-133, 1983","journal-title":"Med Ped Oncol"},{"key":"185582_CR24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00170945","volume":"14","author":"A Hayani","year":"1992","unstructured":"Hayani A, Mahoney DH Jr, Taylor LD: Therapy-related myclodysplastic syndrome in children with medulloblastoma following MOPP chemotherapy. J Neuro-Oncol 14: 57-62, 1992","journal-title":"J Neuro-Oncol"},{"key":"185582_CR25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00390237","volume":"50","author":"A Nora","year":"1979","unstructured":"Nora A, Heideman R, Peakman D, Morse H: Cytogenetic studies in an acute leukemia patient following cerebellar astrocytoma. Human Genet 50: 157-161, 1979","journal-title":"Human Genet"},{"key":"185582_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jso.2930290102","volume":"29","author":"MRSM Pai","year":"1985","unstructured":"Pai MRSM, Advani SH, Gopal R, Nair CN, Saikai T, Kamat DM: Acute leukemia following malignant ependymoma: a case report. J Surg Oncol 29: 1-4, 1985","journal-title":"J Surg Oncol"},{"key":"185582_CR27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0140-6736(90)91956-B","volume":"336","author":"C-H Pui","year":"1990","unstructured":"Pui C-H, Hancock ML, Raimondi SC, Head DR, Thompson E, Wilimas J, Kun LE, Bowman LC, Crist WM, Pratt CB: Myeloid neoplasia in children treated for solid tumours. Lancet 336: 417-421, 1990","journal-title":"Lancet"},{"key":"185582_CR28","first-page":"912","volume":"7","author":"G Perilongo","year":"1993","unstructured":"Perilongo G, Felix CA, Meadow AT, Nowell P, Biegel J, Lange BJ: Sequential development of Wilms tumor, T-cell acate lymphoblastic leukemia, medulloblastoma and myeloid leukemia in a child with type 1 neurofibromatosis: A clinical and cytogenetic case report. Leukemia 7: 912-915, 1993","journal-title":"Leukemia"},{"issue":"8595","key":"185582_CR29","first-page":"1159","volume":"1","author":"GP Redman","year":"1988","unstructured":"Redman GP, Shu S, Norris D: Leukemia and growth hormone [letter]. Lancet 1(8595): 1159-1160, 1988","journal-title":"Lancet"},{"key":"185582_CR30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jjco\/18.1.81","volume":"18","author":"U Sasaki","year":"1988","unstructured":"Sasaki U, Hara M, Watanabe S: Occurrence of acute lymphoblastic leukemia in a boy treated with growth hormone for growth retardation after irradiation to the brain tumor. Jpn J Clin Oncol 18: 81-84, 1988","journal-title":"Jpn J Clin Oncol"},{"key":"185582_CR31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1651-2227.1993.tb12675.x","volume":"82","author":"T Sayli","year":"1993","unstructured":"Sayli T, Cemeroglu AP, Tuncer AM, Gurgey A: Acute lymphoblastic leukemia following optic glioma treated by radiotherapy and surgery. Acta Pacdiatr 82: 327-328, 1993","journal-title":"Acta Pacdiatr"},{"key":"185582_CR32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/1097-0142(197801)41:1<333::AID-CNCR2820410144>3.0.CO;2-7","volume":"41","author":"SE Vogl","year":"1978","unstructured":"Vogl SE: Acute leukemia complicating treatment of glioblastoma multiforme. Cancer 41: 333-336, 1978","journal-title":"Cancer"},{"key":"185582_CR33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1227\/00006123-198011000-00001","volume":"7","author":"M Saleman","year":"1980","unstructured":"Saleman M: Survival in glioblastoma: historical perspective. Neurosurgery 7: 435-439, 1980","journal-title":"Neurosurgery"},{"key":"185582_CR34","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1227\/00006123-199305000-00003","volume":"32","author":"K Chandler","year":"1993","unstructured":"Chandler K, Prados MD, Malec M, Wilson CB: Long-term survival in patients with glioblastoma multiforme. Neurosurgery 32: 716-720, 1993","journal-title":"Neurosurgery"},{"key":"185582_CR35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1227\/00006123-199402000-00002","volume":"34","author":"M Saleman","year":"1994","unstructured":"Saleman M, Scholtz, Kaplan RS, Kuik S: Long-term survival in patients with malignant astrocytoma. Neurosurgery 34: 213-220, 1994","journal-title":"Neurosurgery"},{"key":"185582_CR36","first-page":"78","volume":"31","author":"JG Cairncross","year":"1992","unstructured":"Cairncross JG, Macdonald DR, Ramsay DA: Aggressive oligodendroglioma: a chemosensitive tumor. Neurosurgery 31: 78-82, 1992","journal-title":"Neurosurgery"},{"key":"185582_CR37","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.1994.12.10.2013","volume":"12","author":"G Cairncross","year":"1994","unstructured":"Cairncross G, Macdonald D, Ludwin S, Lee D, Caseino T, Bucker J, Fulton D, Dropcho E, Stewart D, Schold C Jr, Wainman N, Eisenhauer for the National Cancer Institute of Canada Clinical Trials Group' Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 12: 2013-2021, 1994","journal-title":"J Clin Oncol"},{"key":"185582_CR38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1212\/WNL.46.1.203","volume":"46","author":"WP Mason","year":"1996","unstructured":"Mason WP, Krol GS, DeAngelis LM: Low-grade oligodendroglioma responds to chemotherapy. Neurology 46: 203-207, 1996","journal-title":"Neurology"},{"key":"185582_CR39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0360-3016(90)90096-3","volume":"18","author":"VA Levin","year":"1990","unstructured":"Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, Wilson CB: Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vineristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18: 321-324, 1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"185582_CR40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF01052722","volume":"20","author":"HA Fine","year":"1994","unstructured":"Fine HA: The basis of current treatment recommendations for malignant glioma. J Neuro-Oncol 20: 111-120, 1994","journal-title":"J Neuro-Oncol"},{"key":"185582_CR41","first-page":"136","volume":"5","author":"SL Gerson","year":"1993","unstructured":"Gerson SL: Molecular epidemiology of therapy-related leukemia. Curr Opin Oncol 5: 136-144, 1993","journal-title":"Curr Opin Oncol"},{"key":"185582_CR42","first-page":"87","volume":"8","author":"Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique","year":"1994","unstructured":"Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique: Acute leukemia treated with intensive chemotherapy in patients with a history of previous chemo and\/or radiotherapy: Prognostic significance of karyotype and preceding myclodysplastic syndrome. Leukemia 8: 87-91, 1994","journal-title":"Leukemia"},{"key":"185582_CR43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1200\/JCO.1986.4.3.325","volume":"4","author":"MM Le Beau","year":"1986","unstructured":"Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Bough RR, Golomb HM, Rowley JD: Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: Further evidence for characteristic abnormalities of chromosomes no 5 and 7. J Clin Oncol 4: 325-345, 1986","journal-title":"J Clin Oncol"},{"key":"185582_CR44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000132791","volume":"51","author":"L-C Tsui","year":"1989","unstructured":"Tsui L-C, Farrall M, Donis-Keller H: Report of the committee on the genetic constitution of chromosomes 7 and 8. Human Gene mapping 10. Cytogenet Cell Genet 51: 166-201, 1989","journal-title":"Cytogenet Cell Genet"},{"key":"185582_CR45","first-page":"647","volume":"73","author":"MM Le Beau","year":"1989","unstructured":"Le Beau MM, Lemons RS, Espinosa R III, Larson RA, Arai N, Rowley JD: Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del (5q). Blood 73: 647-650, 1989","journal-title":"Blood"},{"key":"185582_CR46","first-page":"139","volume":"21","author":"AJ Wong","year":"1994","unstructured":"Wong AJ, Zoltick PW, Moscattello DK: The molecular biology and molecular genetics of astrocytic neoplasms. Sem Oncol 21: 139-148, 1994","journal-title":"Sem Oncol"},{"key":"185582_CR47","first-page":"405","volume":"48","author":"SH Bigner","year":"1988","unstructured":"Bigner SH, Mark J, Burger PC, Mahaley MS Jr, Bullard DE, Muhlbaier LH, Bigner DD: Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 48: 405-411, 1988","journal-title":"Cancer Res"},{"key":"185582_CR48","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1200\/JCO.1986.4.6.830","volume":"4","author":"S Valagussa","year":"1986","unstructured":"Valagussa S, Santoro A, Fossati-Bellani F, Banfi A, Bonadonna G: Secondary acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol 4: 830-837, 1986","journal-title":"J Clin Oncol"},{"key":"185582_CR49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/mutage\/3.2.83","volume":"3","author":"D Clive","year":"1988","unstructured":"Clive D, Truner N, Krehl R: Procarbazine is a potent mutagen at the heterozygous thymidine kinase locus of mouse lymphoma assay. Mutagenesis 3: 83-87, 1988","journal-title":"Mutagenesis"},{"key":"185582_CR50","first-page":"2125","volume":"38","author":"SM Sieber","year":"1978","unstructured":"Sieber SM, Correa P, Dalgard DW, Adamson RH: Carcinogenic and other adverse effects of procarbazine in nonhuman primates. Cancer Res 38: 2125-2134, 1978","journal-title":"Cancer Res"},{"key":"185582_CR51","first-page":"1121","volume":"46","author":"RW O'Gara","year":"1971","unstructured":"O'Gara RW, Adamson RH, Kelly MG, Dalgard DW: Neoplasms of the hematopoietic system in nonhuman primates: report of one spontaneous tumor and two leukemias induced by procarbazinc. J Natl Cancer Inst 46: 1121-1130, 1971","journal-title":"J Natl Cancer Inst"},{"key":"185582_CR52","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0889-8588(18)30243-0","volume":"7","author":"LN Shulman","year":"1993","unstructured":"Shulman LN: The biology of alkylating-agent cellular injury. Hematol Oncol Clin N Amer 7: 325-335, 1993","journal-title":"Hematol Oncol Clin N Amer"},{"key":"185582_CR53","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJM199005173222004","volume":"322","author":"CR Nichols","year":"1990","unstructured":"Nichols CR, Roth BJ, Heerema N, Griep J, Tricot G: Hematologic neoplasia associated with primary mediastinal germ cell tumors. N Engl J Med 322: 1425-1429, 1990","journal-title":"N Engl J Med"},{"key":"185582_CR54","first-page":"237","volume":"64","author":"VA Levin","year":"1980","unstructured":"Levin VA, Edwards MS, Wright DC, Seager ML, Schimberg TP, Townsend JJ, Wilson CB: Modified procarbazine, CCNU, and vineristine (PCV-3) combination chemotherapy in the treatment of malignant primary brain tumors. Cancer Treat Rep 64: 237-241, 1980","journal-title":"Cancer Treat Rep"},{"key":"185582_CR55","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0889-8588(18)30253-3","volume":"7","author":"KK Ballen","year":"1993","unstructured":"Ballen KK, Antin JH: Treatment of therapy-related acute myclogenous leukemia and myelodysplastic syndromes. Hematol Oncol Clin N Amer 7: 477-493, 1993","journal-title":"Hematol Oncol Clin N Amer"},{"key":"185582_CR56","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0959-8049(94)00284-C","volume":"30A","author":"CF Hess","year":"1994","unstructured":"Hess CF, Kortmann RD, Schmidberger II, Bamberg M: How relevant is secondary leukemia for initial treatment selection in Hodgkin's disease? Eur J Cancer 30A: 1441-1447, 1994","journal-title":"Eur J Cancer"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006175831785.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006175831785\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006175831785.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:09:53Z","timestamp":1749632993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006175831785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["185582"],"URL":"https:\/\/doi.org\/10.1023\/a:1006175831785","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,10]]}}}